Glutathione bought for skin is bought in two very different ways, and only one of them has a lawful price. A compounded injection runs a typical $149 a month across 96 sellers that publish a monthly figure, while the whitening kits sold online for the same purpose are unapproved drugs. The distinction is not a technicality. It decides who made the vial, under what standard, and what happens when something goes wrong.
| Route | Sellers | Lowest | Typical | Highest |
|---|---|---|---|---|
| Injection | 96 | $57.32 | $149 | $389.99 |
| Nasal spray | 16 | $83 | $130 | $249 |
| Swallowed | 4 | $139 | $202 | $297 |
| Under the tongue | 4 | $125 | $132 | $169 |
The injection's typical month runs $53 below the swallowed form's, and the spread inside either column is wider than that gap. The route-by-route arithmetic is worked through in glutathione injection cost, and the clinic drip is priced separately in glutathione IV cost.
What the molecule is, and what it is claimed to do
Glutathione is a low-molecular-weight thiol tripeptide with a role in maintaining intracellular redox balance, and the discovery of antimelanogenic properties is what turned it into a lightening product[1].
The proposed mechanism is direct and indirect inhibition of tyrosinase, and a switch from eumelanin toward phaeomelanin production[1].
The same review is unusually direct about the commercial side, describing the hype around the depigmentary claim as possibly a marketing device[1].
What has actually been randomized
The trials that found an effect gave glutathione by mouth, at doses a supplement aisle would recognize rather than a pharmacy.
In a randomized, double-blind, placebo-controlled study, 60 healthy adults took 500 mg a day in two divided doses, or placebo, for four weeks[2].
Melanin indices fell at all six measured sites in the glutathione group[2]. The reduction was statistically greater than placebo at two of them, the right side of the face and the sun-exposed left forearm, at p = 0.021 and p = 0.036[2]. The authors described the result as lightening in a small number of subjects, with long-term safety not established[2].
A second randomized, double-blind, placebo-controlled study used a lower dose, 250 mg a day of either the reduced or the oxidized form, for twelve weeks in healthy female subjects[3]. Melanin index and ultraviolet spots tended to be lower than placebo, and at some sites the reduced form showed a significant reduction in wrinkles[3].
On the injected route, the 2016 review is blunt: although intravenous glutathione injections are popular, there is no evidence to prove their efficacy[1]. It also records that adverse effects led a national regulator to issue a public warning against the off-label lightening use[1].
What FDA has done about the products sold for this
In January 2018, under a consent decree of permanent injunction ordered in federal court, an online seller recalled every lot of nineteen products that FDA alleged were misbranded or unapproved new drugs[4].
The recalled list is the shape of this market. It was made up of multi-vial glutathione whitening kits at 600, 900, 1,200, 1,400, 1,500, 1,800 and 3,000 mg per vial, sold alone or with ampules of vitamin C and sterile water[4].
The compounding side has its own record. In 2019, FDA reported that seven patients at one outpatient clinic each received 7 mL, or 1,400 mg, of an intravenous drug compounded from repackaged L-glutathione[5]. Within minutes they experienced nausea, vomiting, lightheadedness, chills, body aches and sneezing[5].
One of those patients developed low blood pressure and difficulty breathing and was transferred to hospital[5]. A second report a few weeks later described a patient admitted with chills, fever and shaking after a 2,400 mg infusion from a different pharmacy[5].
FDA tested samples and found excessive bacterial endotoxin, with some results as high as five times the limit it calculated for the doses received[5]. The powder carried the label “Caution: Dietary Supplement” and should not have been used to compound sterile injectables[5].
FDA repeated the warning in 2026, saying it remains concerned about continued risks to patients and that health care professionals should check with their compounders about the source of the glutathione used[6].
Where the lawful product sits
Glutathione itself is in 503A Category 1, the group of bulk substances FDA has under evaluation, which is what lets a pharmacy compound it at all[7]. That listing says nothing about lightening, and it is not an approval.
So a prescription can lawfully exist for a compounded glutathione product while no approved drug exists for the use most buyers have in mind. Reading the difference off a checkout page is covered in RUO peptides and the compounded peptides guide.
Questions worth asking before paying
- Is the product compounded by a named pharmacy, and what grade of glutathione is used?
- What does the monthly price buy in milligrams, and how many administrations?
- Is a consult or membership fee billed on top, and what does month two cost?
The oral and liposomal end of the same market, where most of the randomized evidence sits, is priced in liposomal glutathione. The fees beside any of these figures are listed in peptide therapy cost.